FIRST SEQUENTIAL ASSESSMENT AT 6 MONTHS AND 2 YEARS OF THE 2ND GENERATION ABSORB EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLD: A MULTI-IMAGING MODALITY STUDY

Yoshinobu Onuma; Cécile Dorange; Karine Miquel‐Hébert; Patrick W. Serruys

doi:10.1016/s0735-1097(12)60318-0

Related publications

Article2012

First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold

John A. Ormiston, Patrick W. Serruys, Yoshinobu Onuma, Robert‐Jan van Geuns, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel Hebert, Richard Rapoza, Héctor M. García‐García

Circulation Cardiovascular Interventions

Article2013

Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment

Héctor M. García‐García, Carl Schultz, Eric Duckers, Evelyn Regar, Jürgen Ligthart, Patrick W. Serruys, Robert‐Jan van Geuns

EuroIntervention

Article2016

TCT-431 RANDOMIZED COMPARISON OF ABSORB BIORESORBABLE VASCULAR SCAFFOLD AND MIRAGE MICROFIBER SIROLIMUS ELUTING SCAFFOLD USING MULTI-MODALITY IMAGING

Teguh Santoso, Huong Bang Liew, Erhan Tenekecioğlu, Ricardo A. Costa, Daniel Chamié, Solomon Su, Alexandre Abizaid, Christos V. Bourantas, Ryo Torii, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2014

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

Patrick W. Serruys, Yoshinobu Onuma, Héctor M. García‐García, Takashi Muramatsu, Robert‐Jan van Geuns, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel Hebert, Richard Rapoza, John A. Ormiston

EuroIntervention

Article2015

TCT-11 Five-year Follow up of the First in Man use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis; A Serial Multi-Imaging Modality Study

Patrick W. Serruys, Yoshinobu Onuma, Robert J. Van Geuns, Bernard De Bruyne, Dariusz Dudek, Evald Høj Christiansen, Bernard Chevalier, Pieter C. Smits, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Luc Wasungu, Divine Ediebah, Susan Veldhof, John A. Ormiston